Literature DB >> 15886356

Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle.

Joseph M McClung1, Kristen A Mehl, Raymond W Thompson, Larry L Lowe, James A Carson.   

Abstract

Functionally overloading rat soleus muscle by synergist ablation induces a rapid increase in mass. Muscle remodeling during the first week of overload is critical for the overload-induced growth. Anabolic steroid modulation of this overload-induced remodeling response is not well understood. The purpose of this study was to determine whether pretreatment with nandrolone decanoate, a clinically administered anabolic steroid, alters muscle morphology and gene expression related to muscle growth during the initiation of functional overload in the rat soleus muscle. Adult (5 mo) male Fisher 344 x Brown Norway rats were randomly assigned to control (Sham), 3-day functional overload (OV), nandrolone decanoate administration (ND), or 3-day functional overload with nandrolone decanoate administration (OV+ND) treatment groups. Morphologically, OV increased the percentage of small (361%) and large (150%) fibers and expanded the ECM 50%. ND administration decreased the 3-day OV induction of small fibers 51% and nuclei associated with the ECM 20%. ND administration also attenuated the induction of cell cycle regulator p21 (64%) and myogenin (37%) mRNAs after 3 days of overload. These data demonstrate that nandrolone decanoate pretreatment can alter morphological and cell cycle regulator expression related to muscle growth at the onset of functional overload.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886356     DOI: 10.1152/ajpregu.00285.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  Skeletal muscle mass recovery from atrophy in IL-6 knockout mice.

Authors:  T A Washington; J P White; J M Davis; L B Wilson; L L Lowe; S Sato; J A Carson
Journal:  Acta Physiol (Oxf)       Date:  2011-04-27       Impact factor: 6.311

2.  The use of anabolic steroids as a strategy in reversing denervation atrophy after delayed nerve repair.

Authors:  Jonathan Isaacs; Kerry Loveland; Satya Mallu; Scott Adams; Ross Wodicka
Journal:  Hand (N Y)       Date:  2011-04-09

3.  Eccentric contraction-induced myofiber growth in tumor-bearing mice.

Authors:  Justin P Hardee; Joshua E Mangum; Song Gao; Shuichi Sato; Kimbell L Hetzler; Melissa J Puppa; Dennis K Fix; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2015-10-22

4.  Overexpression of antioxidant enzymes in diaphragm muscle does not alter contraction-induced fatigue or recovery.

Authors:  Joseph M McClung; Keith C Deruisseau; Melissa A Whidden; Holly Van Remmen; Arlan Richardson; Wook Song; Ioannis S Vrabas; Scott K Powers
Journal:  Exp Physiol       Date:  2009-09-25       Impact factor: 2.969

5.  Overload-induced skeletal muscle extracellular matrix remodelling and myofibre growth in mice lacking IL-6.

Authors:  J P White; J M Reecy; T A Washington; S Sato; M E Le; J M Davis; L B Wilson; J A Carson
Journal:  Acta Physiol (Oxf)       Date:  2009-08-03       Impact factor: 6.311

Review 6.  Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease.

Authors:  James A Carson; Stavros C Manolagas
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

7.  Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.

Authors:  James P White; Kristen A Baltgalvis; Shuichi Sato; L Britt Wilson; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

Review 8.  Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.

Authors:  Peter Greaves; Luc Chouinard; Heinrich Ernst; Lars Mecklenburg; Ingrid M Pruimboom-Brees; Matthias Rinke; Susanne Rittinghausen; Stéphane Thibault; Jasmin Von Erichsen; Toshinori Yoshida
Journal:  J Toxicol Pathol       Date:  2013       Impact factor: 1.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.